{
    "pmcid": "9393763",
    "qa_pairs": {
        "How do nanobodies potentially inhibit the SARS-CoV-2 virus's ability to bind to host cells?": [
            "By stabilizing the receptor-binding domain (RBD) in the 'down' conformation, preventing ACE2 binding.",
            "By degrading the spike protein, rendering it non-functional.",
            "By binding to the ACE2 receptor directly, blocking the virus's access.",
            "By inducing the spike protein to dissociate from the virus surface."
        ],
        "What challenge is associated with the development of nanobodies for SARS-CoV-2 therapeutics?": [
            "Ensuring sufficient neutralizing potency and avoiding escape mutations.",
            "Achieving high production costs and long development times.",
            "Maintaining activity at extremely low temperatures.",
            "Preventing degradation in acidic environments."
        ],
        "What is a key structural advantage of nanobodies over conventional antibodies in targeting the SARS-CoV-2 spike protein?": [
            "Nanobodies can access cryptic epitopes that are less accessible to larger antibodies.",
            "Nanobodies have a higher binding affinity to the spike protein than conventional antibodies.",
            "Nanobodies can bind to multiple sites on the spike protein simultaneously.",
            "Nanobodies are able to penetrate the viral membrane more effectively than conventional antibodies."
        ],
        "What is one method mentioned for optimizing nanobodies for increased affinity and stability?": [
            "Affinity maturation and structure-guided design.",
            "Genetic recombination and hybridization.",
            "Chemical modification and cross-linking.",
            "Thermal cycling and pressure treatment."
        ],
        "What therapeutic advantage do nanobodies have due to their small size and stability?": [
            "They can be administered via inhalation, which is relevant for respiratory viruses.",
            "They can be delivered orally, bypassing the need for injections.",
            "They can be integrated into vaccines as adjuvants.",
            "They can be used to coat surfaces for long-term viral protection."
        ]
    }
}